Source:http://linkedlifedata.com/resource/pubmed/id/20197529
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
2010-3-3
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
1538-3598
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
3
|
| pubmed:volume |
303
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
836; author reply 836
|
| pubmed:meshHeading |
pubmed-meshheading:20197529-Antidepressive Agents,
pubmed-meshheading:20197529-Depressive Disorder, Major,
pubmed-meshheading:20197529-Fatty Acids, Omega-3,
pubmed-meshheading:20197529-Psychiatric Status Rating Scales,
pubmed-meshheading:20197529-Reproducibility of Results,
pubmed-meshheading:20197529-Sertraline,
pubmed-meshheading:20197529-Treatment Outcome
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Omega-3 fatty acids for CHD with depression.
|
| pubmed:publicationType |
Letter,
Comment
|